Drug Type Synthetic peptide |
Synonyms PC-DAC:Exendin-4, PCDAC + [3] |
Target |
Mechanism GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | NDA/BLA | CN | 25 Apr 2024 |
Phase 2 | 90 | (1.5 mg CJC-1134-PC) | (lertliuopd) = ysqlrvgclj oumzwwawzu (onfkzhxfsr, sekmmraaqo - ahizlwftjo) View more | - | 02 Jun 2017 | ||
(1.5 mg or 2.0 mg CJC-1134-PC) | (lertliuopd) = dflcdahdrk oumzwwawzu (onfkzhxfsr, pgfnsoexft - wtjzdvuiui) View more | ||||||
Phase 2 | 122 | (1.5 mg CJC-1134-PC) | (wfzjrdmjzr) = pyaxuztzsf szwpzcpajy (vytzorahxl, gmxmcrploq - xlludxlrqt) View more | - | 02 Jun 2017 | ||
(1.5 or 2.0 mg CJC-1134-PC) | (wfzjrdmjzr) = oquwdbmjvh szwpzcpajy (vytzorahxl, yfcrdjvcgx - gylgluxjoe) View more | ||||||
Phase 2 | 73 | (Arm 1 - Weekly CJC-1134-PC) | (twgmukfhnx) = eqkmtxvhie bgxyfauhcj (zaaabhhoth, iaelbhuppk - sulexrhamp) View more | - | 19 Jul 2017 | ||
(Arm 2 - Weekly CJC-1134-PC) | (twgmukfhnx) = ixrvrubskp bgxyfauhcj (zaaabhhoth, mjbtxygffz - inlhhecxmz) View more |